Axsome Therapeutics
AXSM
AXSM
35 hedge funds and large institutions have $12.2M invested in Axsome Therapeutics in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
7% less capital invested
Capital invested by funds: $13.1M → $12.2M (-$932K)
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
Holders
35
Holding in Top 10
1
Calls
$16K
Puts
$9K
Top Buyers
| 1 | +$955K | |
| 2 | +$770K | |
| 3 | +$328K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$219K |
| 5 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$138K |
Top Sellers
| 1 | -$1.95M | |
| 2 | -$1.92M | |
| 3 | -$141K | |
| 4 |
Barclays
London,
United Kingdom
|
-$117K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$69K |